Gain expert insights in this interview on achieving transfection success. Explore proven strategies to optimize your approach and enhance results.

Explore how nanosensors are transforming cancer diagnostics by enabling earlier, more accurate, and less invasive detection ...

This new lipid nanoparticle production system developed by Shin-Etsu Chemical and Hokkaido University is capable of small-batch and mass production ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

Shin-Etsu Chemical Co., Ltd. (Head Office: Tokyo; President: Yasuhiko Saitoh; hereinafter, "Shin-Etsu Chemical") and Hokkaido University (Location ...

The raise will go toward trialing the company’s lead drug for phosphomannomutase-2 congenital disorder of glycosylation, a ...

Three Johns Hopkins experts discuss the potential of mRNA-powered therapeutics to produce lifesaving treatments and cures for ...

Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, announced that Randall ...

Marama Labs has launched its CloudSpec instrument for nanomedicine development, which is expected to cut time and speed up ...

Q4 2024 Earnings Call Transcript April 10, 2025 CureVac N.V. misses on earnings expectations. Reported EPS is $-0.16564 EPS, ...

The global vaccine CDMO market is set to witness a growth rate of 8% in the next 5 years. Increasing demand for vaccines, ...